These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38521521)

  • 1. Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study).
    Green A; Newton RU; Smith DP; Tuffaha H; Galvão DA; Heathcote P; Patel MI; Christie D; Egger S; Sara SA; Heneka N; Chambers SK; Dunn J
    BMJ Open; 2024 Mar; 14(3):e084412. PubMed ID: 38521521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of educational and psychological survivorship interventions to improve health-related quality of life outcomes for men with prostate cancer on androgen deprivation therapy: a systematic review.
    Sara SA; Heneka N; Green A; Chambers SK; Dunn J; Terry VR
    BMJ Open; 2024 May; 14(5):e080310. PubMed ID: 38777593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2).
    Crabb S; Morgan A; Hunter MS; Stefanopoulou E; Griffiths G; Richardson A; Fenlon D; Fleure L; Raftery J; Boxall C; Wilding S; Nuttall J; Eminton Z; Tilt E; O'Neill A; Bacon R; Martin J
    Trials; 2023 Jul; 24(1):450. PubMed ID: 37430353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trial.
    Watson E; Rose P; Frith E; Hamdy F; Neal D; Kastner C; Russell S; Walter FM; Faithfull S; Wolstenholme J; Perera R; Weller D; Campbell C; Wilkinson C; Neal R; Sooriakumaran P; Butcher H; Matthews M
    BMJ Open; 2014 May; 4(5):e005186. PubMed ID: 24852301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation.
    McNaught E; Reale S; Bourke L; Brown JE; Collinson M; Day F; Hewison J; Farrin AJ; Ibeggazene S; Innes AQ; Mason E; Meads D; Scope A; Taylor C; Taylor SJ; Turner RR; Rosario DJ;
    Trials; 2024 Apr; 25(1):257. PubMed ID: 38610058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.
    Siltari A; Riikonen J; Koskimäki J; Pakarainen T; Ettala O; Boström P; Seikkula H; Kotsar A; Tammela T; Helminen M; Raittinen PV; Lehtimäki T; Fode M; Østergren P; Borre M; Rannikko A; Marttila T; Salonen A; Ronkainen H; Löffeler S; Murtola TJ
    BMJ Open; 2022 Apr; 12(4):e050264. PubMed ID: 35487730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
    Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV).
    Watson EK; Shinkins B; Matheson L; Burns RM; Frith E; Neal D; Hamdy F; Walter FM; Weller D; Wilkinson C; Faithfull S; Sooriakumaran P; Kastner C; Campbell C; Neal RD; Butcher H; Matthews M; Perera R; Wolstenholme J; Rose PW
    Eur J Oncol Nurs; 2018 Feb; 32():73-81. PubMed ID: 29353635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
    Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN
    BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial.
    Schofield P; Gough K; Lotfi-Jam K; Bergin R; Ugalde A; Dudgeon P; Crellin W; Schubach K; Foroudi F; Tai KH; Duchesne G; Sanson-Fisher R; Aranda S
    BMC Cancer; 2016 Aug; 16():637. PubMed ID: 27530156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial.
    Connor MJ; Shah TT; Smigielska K; Day E; Sukumar J; Fiorentino F; Sarwar N; Gonzalez M; Falconer A; Klimowska-Nassar N; Evans M; Naismith OF; Thippu Jayaprakash K; Price D; Gayadeen S; Basak D; Horan G; McGrath J; Sheehan D; Kumar M; Ibrahim A; Brock C; Pearson RA; Anyamene N; Heath C; Shergill I; Rai B; Hellawell G; McCracken S; Khoubehi B; Mangar S; Khoo V; Dudderidge T; Staffurth JN; Winkler M; Ahmed HU
    BMJ Open; 2021 Feb; 11(2):e042953. PubMed ID: 33632752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial interventions for men with prostate cancer.
    Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008529. PubMed ID: 24368598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial).
    Galvão DA; Taaffe DR; Hayne D; Lopez P; Lyons-Wall P; Tang CI; Chambers SK; Devine A; Spry N; Jeffery E; Kudiarasu C; Joseph D; Newton RU
    BMJ Open; 2022 Jun; 12(6):e058899. PubMed ID: 35667725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the 'FC Prostate' randomized controlled trial.
    Uth J; Schmidt JF; Christensen JF; Hornstrup T; Andersen LJ; Hansen PR; Christensen KB; Andersen LL; Helge EW; Brasso K; Rørth M; Krustrup P; Midtgaard J
    BMC Cancer; 2013 Dec; 13():595. PubMed ID: 24330570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial.
    Zhao X; Wang T; Ye Y; Li J; Gao X; Zhang H
    BMJ Open; 2022 Sep; 12(9):e051371. PubMed ID: 36180115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer.
    Gilbert DC; Duong T; Kynaston HG; Alhasso AA; Cafferty FH; Rosen SD; Kanaga-Sundaram S; Dixit S; Laniado M; Madaan S; Collins G; Pope A; Welland A; Nankivell M; Wassersug R; Parmar MK; Langley RE; Abel PD
    BJU Int; 2017 May; 119(5):667-675. PubMed ID: 27753182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
    Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
    Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomised controlled trial protocol (the T-CRF trial).
    Ladwa R; Pinkham EP; Teleni L; Hanley B; Lock G; Nixon J; Agbejule OA; Crawford-Williams F; Jones L; Pinkham MB; Turner J; Yates P; McPhail SM; Aitken JF; Escalante CP; Hart NH; Chan RJ
    BMJ Open; 2022 May; 12(5):e059952. PubMed ID: 35577469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.